Delivery Order SPE2DB22D1200-SPE2DB23FN2FP
Award Date 5/15/23
Potential Completion Date 5/16/23
Potential Value $3.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,114.21 Firm Fixed Price delivery order is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Colestipol HCl 1 GM tablets. The contract is a Delivery Order valued at $7,352.07 with a firm fixed price, and has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
- This federal contract award, with the ID SPE2DX15D2101|SPE2DX24F48LB, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,262.06 firm fixed-price delivery order is for the supply of Colestipol HCL 1 GM Tablets to support federal healthcare programs. The award has an ultimate completion date of November 20, 2023 and was made on November 17, 2023. This contract is not designated as a set-aside....
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Colestipol HCL 1 GM tablets. The contract, valued at $1,020.64, was awarded by the Defense Logistics Agency (DLA) on June 6, 2024, with a completion date of June 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,369.79 firm fixed price delivery order is for the supply of Colestipol Hydrochloride 1 gram tablets. The award is not associated with any set-aside program. The prime contractor, Amerisourcebergen Drug Corp, has provided a wide range of pharmaceutical products and medical supplies...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a Delivery Order contract valued at $1,544.56 for the supply of Colestipol HCL 1 GM Tablets. The award is not associated with a set-aside program and appears to be an open competition contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Colestipol HCL 1 GM Tablet in quantities of 120 tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $3,439.77 and is a firm fixed-price delivery order type. The contract has an ultimate completion date of November 17, 2023 and was awarded on November 16, 2023. There is no set-aside...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,558.53 placed by the Defense Logistics Agency (DLA) for the supply of COLESTID 1 GM TABLET 120S. The award has an ultimate completion date of October 10, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,106.98, is for the delivery of Colestipol HCL 1 GM Tablets in quantities of 120s. The contract has an ultimate completion date of March 18, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,462.98 contract is for the delivery of 120 count tablets of Colestipol HCl 1 GM, a medication used to treat high cholesterol. The contract has a completion date of May 9, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...